Gabey Goh
Apr 5, 2016

Pfizer Korea awards media business to Omnicom Media Group

SOUTH KOREA – Pfizer Korea has awarded Omnicom Media Group its media duties for the market, following a media review.

Pfizer Korea awards media business to Omnicom Media Group

According to industry sources, it is understood that the pitch process included incumbent agency Cheil Worldwide, with GroupM and Starcom also in the mix.

R3 managed the pitch, but was unavailable for comment. Campaign Asia-Pacific contacted both Omnicom and Cheil for comment but did not receive a response at time of writing.

It has been reported that in Australia, Pfizer recently awarded its media business to Ikon Group Sydney after a closed pitch. The agency takes over from incumbent Match Media.

Earlier this year in February, the pharmaceutical giant moved a portion of its media buying business to IPG Mediabrands in Hong Kong, including some pharmaceutical brands previously held by Mindshare. Brands in the shift included Viagra and Metamucil.

Source:
Campaign Asia

Related Articles

Just Published

1 hour ago

Starbucks APAC VP Samuel Fung steps down

The former VP of Product and Marketing is a two-time Campaign Power List honoree. He exits the role after nearly 12 years with the company.

3 hours ago

Santander on its shift to one global agency, why it ...

Bank has been rethinking its $1 billion-a-year spend on advertising and communications to drive consistency and effectiveness in age of AI.

10 hours ago

40 Under 40 2024: Tim Lindley, VaynerMedia

Lindley’s work at VaynerMedia, balancing strategic vision and growth with empathetic leadership, makes him a standout figure in the APAC marketing landscape.

12 hours ago

How indies are closing the gap between holding ...

In a true David vs. Goliath battle, nimble independent agencies are defying the "bigger is better" narrative, winning top clients and industry awards with smart investments, speed, and agility.